June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Glaucoma Monitoring with Frequency Doubling Perimetry in the Groningen Longitudinal Glaucoma Study
Author Affiliations & Notes
  • Christiaan Wesselink
    Dept. of Ophthalmology, University Medical Center Groningen, Groningen, Netherlands
  • Nomdo Jansonius
    Dept. of Ophthalmology, University Medical Center Groningen, Groningen, Netherlands
    Dept. of Epidemiology, Erasmus Medical Center, Rotterdam, Netherlands
  • Footnotes
    Commercial Relationships Christiaan Wesselink, None; Nomdo Jansonius, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3937. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christiaan Wesselink, Nomdo Jansonius; Glaucoma Monitoring with Frequency Doubling Perimetry in the Groningen Longitudinal Glaucoma Study. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3937.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To determine the suitability of frequency doubling perimetry (FDT) for glaucoma monitoring.

 
Methods
 

One hundred twenty six eyes of 126 glaucoma patients were included. Patients were followed prospectively with the Humphrey Field Analyzer (HFA; 30-2 SITA) and FDT (C20-1 full threshold) in the Groningen Longitudinal Glaucoma Study, an observational cohort study. The rate of progression (ROP) was calculated. We used the mean deviation (MD) for HFA and the number of test locations with p < 1% in the total deviation probability plot for FDT. Patients were stratified in three equally sized groups (tertiles; slow, average and fast progressors) based on their ROP, for both HFA and FDT.

 
Results
 

On average 8.1 HFA and 4.5 FDT tests were available after a mean follow-up (identical for HFA and FDT) of 6.4 years. The mean (SD) HFA MD at baseline was -7.9 (6.4) dB; the mean (SD) number of abnormal FDT test locations at baseline was 6.1 (4.5). The mean (SD) HFA ROP was -0.28 (0.55) dB/yr and the mean (SD) FDT ROP was 0.12 (0.50) abnormal test locations per year. There was a highly significant association between HFA and FDT ROP (chi-squared test: p<0.001; see figure).

 
Conclusions
 

Using frequency doubling perimetry for the monitoring of glaucoma patients can give some insight in disease progression. This suggests that FDT can be used in patients who cannot be reliably tested with standard automated perimetry.

  
Keywords: 642 perimetry • 758 visual fields  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×